Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I)
- PMID: 22773246
- DOI: 10.1007/s10545-012-9508-8
Characterisation of the T cell and dendritic cell repertoire in a murine model of mucopolysaccharidosis I (MPS I)
Abstract
Background: Mucopolysaccharidosis I (MPS I) is a metabolic disorder caused by α-L-Iduronidase (IDUA) deficiency, resulting in lysosomal accumulation of heparan (HS) and dermatan sulphate (DS). This has been reported in microglia, yet currently the effect of IDUA deficiency on T cells and dendritic cells (DC) and their functionality in disease pathogenesis remains unclear.
Methods: Peripheral blood was collected from 3 month old C57BL/6 MPS I (n = 11) and wildtype (WT) (n = 6) mice. T cell and DC phenotype and functional characteristics were identified by flow cytometry.
Results: MPS I mice exhibited a reduction in DC (p = <0.001) along with CD8+ cytotoxic (p = 0.01) and CD4+ T helper (p = 0.032) cells, compared to WT controls. MPS I DC displayed a significant decrease in cell surface CD123 (p = 0.02) and CD86 (p = 0.006) expression. Furthermore, CD45RB expression was significantly reduced on T helper cells in the MPS I population (p = 0.019).
Conclusion: We report a reduction in circulating DC and T cells in the MPS I mouse; indicative of adaptive immune dysfunction. DC reduction may occur in response to down-regulation of the IL-3 receptor (CD123), necessary for DC survival. We also report down-regulation of cell surface CD86, a molecule required for T cell co-stimulation. T helper cell down-regulation of CD45RB is redolent of an anti-inflammatory phenotype with poor proliferative capacity. The definitive causes of our findings and the consequences and role that these findings play in the pathogenesis of MPS are unclear, but may be in response to lysosomal storage of unmetabolized HS and DS.
Similar articles
-
Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity.J Inherit Metab Dis. 2014 Jan;37(1):1-12. doi: 10.1007/s10545-013-9613-3. Epub 2013 May 8. J Inherit Metab Dis. 2014. PMID: 23653226 Review.
-
A novel role for IL-3: human monocytes cultured in the presence of IL-3 and IL-4 differentiate into dendritic cells that produce less IL-12 and shift Th cell responses toward a Th2 cytokine pattern.J Immunol. 2002 Jun 15;168(12):6199-207. doi: 10.4049/jimmunol.168.12.6199. J Immunol. 2002. PMID: 12055233
-
Morphological damage in Sertoli, myoid and interstitial cells in a mouse model of mucopolysaccharidosis type I (MPS I).Mol Biol Rep. 2021 Jan;48(1):363-370. doi: 10.1007/s11033-020-06055-5. Epub 2020 Dec 15. Mol Biol Rep. 2021. PMID: 33319323
-
[The regulatory effect and mechanism of Astragalus polysaccharides on CD11c(high)CD45RB(low) dendritic cell].Zhonghua Shao Shang Za Zhi. 2011 Apr;27(2):95-9. Zhonghua Shao Shang Za Zhi. 2011. PMID: 21651844 Chinese.
-
Differences in MPS I and MPS II Disease Manifestations.Int J Mol Sci. 2021 Jul 23;22(15):7888. doi: 10.3390/ijms22157888. Int J Mol Sci. 2021. PMID: 34360653 Free PMC article. Review.
Cited by
-
Mucopolysaccharide diseases: a complex interplay between neuroinflammation, microglial activation and adaptive immunity.J Inherit Metab Dis. 2014 Jan;37(1):1-12. doi: 10.1007/s10545-013-9613-3. Epub 2013 May 8. J Inherit Metab Dis. 2014. PMID: 23653226 Review.
-
Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.Biochim Biophys Acta. 2016 Jul;1862(7):1324-36. doi: 10.1016/j.bbadis.2016.04.011. Epub 2016 Apr 19. Biochim Biophys Acta. 2016. PMID: 27101989 Free PMC article.
-
Leukocyte Imbalances in Mucopolysaccharidoses Patients.Biomedicines. 2023 Jun 13;11(6):1699. doi: 10.3390/biomedicines11061699. Biomedicines. 2023. PMID: 37371793 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials